Yellow Fever Vaccine
Yellow Fever Vaccine is a live attenuated viral vaccine used to prevent yellow fever, a mosquito-borne viral disease caused by the yellow fever virus. It is primarily recommended for individuals living in or travelling to areas where yellow fever is endemic, particularly parts of Africa and South America. It works by stimulating the immune system to produce antibodies and develop long-lasting immunity against the yellow fever virus. This helps prevent infection and serious complications such as liver damage, haemorrhage, and organ failure. The vaccine is administered as a single subcutaneous or intramuscular injection. A single dose generally provides long-lasting, often lifelong, protection. Common side effects include mild fever, headache, muscle pain, fatigue, and soreness at the injection site. Rare but serious adverse effects include severe allergic reactions, yellow fever vaccine-associated viscerotropic disease, and neurological complications. It is contraindicated in certain individuals, including those with severe immunodeficiency or a history of serious allergy to vaccine components. Medical assessment is recommended before vaccination.
Yellow Fever Vaccine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Yellow Fever Vaccine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Yellow Fever Vaccine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Yellow Fever Vaccine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
